|
| 35190119 | Analyte recovery in LC-MS/MS bioanalysis: An old issue revisited. | Analytica Chimica Acta | 2022 |
| 35680875 | Transformation of dolutegravir into an ultra-long-acting parenteral prodrug formulation. | Nature Communications | 2022 |
| 35476515 | Small-molecule IKKβ activation modulator (IKAM) targets MAP3K1 and inhibits pancreatic tumor growth. | Proceedings of the National Academy of Sciences of the United States of America | 2022 |
| 35402050 | Urinary BA Indices as Prognostic Biomarkers for Complications Associated with Liver Diseases. | International Journal of Hepatology | 2022 |
| 34531390 | Transformation of tenofovir into stable ProTide nanocrystals with long-acting pharmacokinetic profiles. | Nature Communications | 2021 |
| 33959226 | Bile acid indices as biomarkers for liver diseases I: Diagnostic markers. | World Journal of Hepatology | 2021 |
| 34103484 | Lipophilic nanocrystal prodrug-release defines the extended pharmacokinetic profiles of a year-long cabotegravir. | Nature Communications | 2021 |
| 34312680 | Intramuscular and subcutaneous administration of antiretroviral drugs, compared with oral, enhances delivery to lymphoid tissues in BALB/c mice. | Journal of Antimicrobial Chemotherapy | 2021 |
| 34131469 | Bile acid indices as biomarkers for liver diseases II: The bile acid score survival prognostic model. | World Journal of Hepatology | 2021 |
| 32553670 | The selective PPAR-delta agonist seladelpar reduces ethanol-induced liver disease by restoring gut barrier function and bile acid homeostasis in mice. | Transl Res | 2021 |
| 34458739 | Discovery, synthesis and biological characterization of a series of -(1-(1,1-dioxidotetrahydrothiophen-3-yl)-3-methyl-1-pyrazol-5-yl)acetamide ethers as novel GIRK1/2 potassium channel activators. | RSC Medicinal Chemistry | 2021 |
| 32609488 | KVA-D-88, a Novel Preferable Phosphodiesterase 4B Inhibitor, Decreases Cocaine-Mediated Reward Properties . | ACS Chemical Neuroscience | 2020 |
| 31742407 | Synthesis and Characterization of Long-Acting Darunavir Prodrugs. | Molecular Pharmaceutics | 2020 |
| 32341511 | A year-long extended release nanoformulated cabotegravir prodrug. | Nat Mater | 2020 |
| 31610397 | Direct and indirect quantification of phosphate metabolites of nucleoside analogs in biological samples. | Journal of Pharmaceutical and Biomedical Analysis | 2020 |
| 32908958 | The Synergistic Effect of an ATP-Competitive Inhibitor of mTOR and Metformin on Pancreatic Tumor Growth. | Current Developments in Nutrition | 2020 |
| 32679269 | Head-to-head comparative pharmacokinetic and biodistribution (PK/BD) study of two dexamethasone prodrug nanomedicines on lupus-prone NZB/WF1 mice. | Nanomedicine: Nanotechnology, Biology, and Medicine | 2020 |
| 33062163 | Synthesis and SAR Studies of 1-Pyrrolo[2,3-]pyridine-2-carboxamides as Phosphodiesterase 4B (PDE4B) Inhibitors. | ACS Medicinal Chemistry Letters | 2020 |
| 31496683 | Synthesis and characterization of a long-acting emtricitabine prodrug nanoformulation. | International Journal of Nanomedicine | 2019 |
| 30289818 | Pharmacokinetic testing of a first-generation cabotegravir prodrug in rhesus macaques. | AIDS | 2019 |
| 31525692 | A long acting nanoformulated lamivudine ProTide. | Biomaterials | 2019 |
| 31491432 | Creation of a long-acting rilpivirine prodrug nanoformulation. | J Control Release | 2019 |
| 31472458 | Synthesis of a long acting nanoformulated emtricitabine ProTide. | Biomaterials | 2019 |
| 31266936 | Sequential LASER ART and CRISPR Treatments Eliminate HIV-1 in a Subset of Infected Humanized Mice. | Nature Communications | 2019 |
| 31335938 | Assessing the lymphoid tissue bioavailability of antiretrovirals in human primary lymphoid endothelial cells and in mice. | Journal of Antimicrobial Chemotherapy | 2019 |
| 30718161 | Discovery, synthesis and characterization of a series of (1-alkyl-3-methyl-1H-pyrazol-5-yl)-2-(5-aryl-2H-tetrazol-2-yl)acetamides as novel GIRK1/2 potassium channel activators. | Bioorganic and Medicinal Chemistry Letters | 2019 |
| 31299454 | Determination of the in vitro metabolic stability and metabolites of the anticancer derivative riccardin D-N in human and mouse hepatic S9 fractions using HPLC-Q-LIT-MS. | Journal of Pharmaceutical and Biomedical Analysis | 2019 |
| 29402886 | Creation of a long-acting nanoformulated dolutegravir. | Nature Communications | 2018 |
| 28975688 | Simultaneous LC-MS/MS analysis of eicosanoids and related metabolites in human serum, sputum and BALF. | Biomedical Chromatography | 2018 |
| 29059541 | Creation of a nanoformulated cabotegravir prodrug with improved antiretroviral profiles. | Biomaterials | 2018 |
| 29995046 | ProTide generated long-acting abacavir nanoformulations. | Chemical Communications | 2018 |
| 29553879 | Optimizing the preparation and stability of decorated antiretroviral drug nanocrystals. | Nanomedicine | 2018 |
| 29518644 | Simultaneous quantification of intracellular lamivudine and abacavir triphosphate metabolites by LC-MS/MS. | Journal of Pharmaceutical and Biomedical Analysis | 2018 |
| 29785833 | Species differences in bile acids I. Plasma and urine bile acid composition. | Journal of Applied Toxicology | 2018 |
| 29845631 | Species differences in bile acids II. Bile acid metabolism. | Journal of Applied Toxicology | 2018 |
| 28134625 | Autophagy facilitates macrophage depots of sustained-release nanoformulated antiretroviral drugs. | Journal of Clinical Investigation | 2017 |
| 29061742 | Pharmacokinetics of a Long-Acting Nanoformulated Dolutegravir Prodrug in Rhesus Macaques. | Antimicrob Agents Chemother | 2017 |
| 27559685 | Creation of a Long-Acting Nanoformulated 2',3'-Dideoxy-3'-Thiacytidine. | Journal of acquired immune deficiency syndromes (1999) | 2017 |
| 27565555 | Novel fluorinated pyrrolomycins as potent anti-staphylococcal biofilm agents: Design, synthesis, pharmacokinetics and antibacterial activities. | European Journal of Medicinal Chemistry | 2016 |
| 27344632 | Quantitative analysis of endogenous compounds. | Journal of Pharmaceutical and Biomedical Analysis | 2016 |
| 27456759 | Development and characterization of a long-acting nanoformulated abacavir prodrug. | Nanomedicine | 2016 |
| 27352248 | Pharmacokinetic studies of a novel trioxane antimalarial (99/411) in rats and monkeys using LC-MS/MS. | Biomedical Chromatography | 2016 |
| 25223962 | Peripherally cross-linking the shell of core-shell polymer micelles decreases premature release of physically loaded combretastatin A4 in whole blood and increases its mean residence time and subsequent potency against primary murine breast tumors after I | Pharmaceutical Research | 2015 |
| 25869245 | Irreversible binding of an anticancer compound (BI-94) to plasma proteins. | Xenobiotica | 2015 |
| 25691324 | Aryl hydantoin Ro 13-3978, a broad-spectrum antischistosomal. | Journal of Antimicrobial Chemotherapy | 2015 |
| 25344563 | Urinary bile acids as biomarkers for liver diseases II. Signature profiles in patients. | Toxicological Sciences | 2015 |
| 25344562 | Urinary bile acids as biomarkers for liver diseases I. Stability of the baseline profile in healthy subjects. | Toxicological Sciences | 2015 |
| 26218293 | Impaired synaptic development in a maternal immune activation mouse model of neurodevelopmental disorders. | Brain, Behavior, and Immunity | 2015 |
| 24258703 | Liquid chromatography tandem mass spectrometry method for determination of antidiabetic chalcones derivative S001-469 in rat plasma, urine and feces: application to pharmacokinetic study. | Drug Research | 2014 |
| 25288084 | Pharmacokinetics, biodistribution, and toxicity of folic acid-coated antiretroviral nanoformulations. | Antimicrob Agents Chemother | 2014 |